Vaccination against Hepatitis B: A Scoping Review
- PMID: 33369439
- PMCID: PMC8046310
- DOI: 10.31557/APJCP.2020.21.12.3453
Vaccination against Hepatitis B: A Scoping Review
Abstract
Objective: Elimination of viral hepatitis by 2030 as one of the international Sustainable Development Goals puts the hepatitis B vaccination on the forefront. However, barriers to vaccination reported in various studies are of concern. This study explores the global barriers for effective uptake of Hepatitis-B vaccination.
Methods: A scoping review of studies reporting hepatitis B vaccination barriers was done using PMC data base and Google scholar search engine. About 803 journal articles and reports on hepatitis B barriers were retrieved but only 36 most relevant items during last 10 years were identified, pile sorted, grouped and analyze.
Results: Overall 74 barriers have been identified for effective uptake of hepatitis-B vaccines. Most studies focused on non-zero dose of hepatitis B vaccine, One-third of the barriers are related to system issues, one-fourth of the barriers were related to caregiver education or awareness, fear of side effect, migration etc., one-fifth barriers were related to service provider issues like poor out-reach, home visits, poor communication and/relation with the caregivers, failure to identify unimmunized children etc., and other barriers were social-cultural issues. The review reveals limited availability and accessibility to health-facility based immunization, lack of awareness among caregivers, poor communication by the healthcare workers and negative relationships with the beneficiaries, cost of vaccine in private sector, inconvenience time and place of vaccination etc. as the major barriers for hepatitis B vaccination. Barriers varied from country to country.
Conclusion: Myriad barriers for reduced hepatitis-B vaccine uptake need to be addressed contextually as countries are at different stages of hepatitis-B vaccination implementation.
Keywords: Barriers; Hepatitis B; Immunization; Sustainable development goal.
Similar articles
-
Full-dose hepatitis B virus vaccination coverage and associated factors among health care workers in Ethiopia: A systematic review and meta-analysis.PLoS One. 2020 Oct 27;15(10):e0241226. doi: 10.1371/journal.pone.0241226. eCollection 2020. PLoS One. 2020. PMID: 33108365 Free PMC article.
-
Assessment of the hepatitis B birth dose vaccination program, Papua New Guinea, 2014.Vaccine. 2016 Jan 12;34(3):367-72. doi: 10.1016/j.vaccine.2015.11.044. Epub 2015 Nov 25. Vaccine. 2016. PMID: 26620839
-
Barriers to hepatitis B vaccine coverage among healthcare workers in the Republic of Georgia: An international perspective.Infect Control Hosp Epidemiol. 2010 Feb;31(2):158-64. doi: 10.1086/649795. Infect Control Hosp Epidemiol. 2010. PMID: 20038247
-
Prevention and care of hepatitis B in the rural region of Fatick in Senegal: a healthcare workers' perspective using a mixed methods approach.BMC Health Serv Res. 2019 Sep 4;19(1):627. doi: 10.1186/s12913-019-4416-3. BMC Health Serv Res. 2019. PMID: 31484515 Free PMC article.
-
Towards contextualized complex systems approaches to scaling-up hepatitis B birth-dose vaccination in the African region: a qualitative systematic review.Front Public Health. 2024 Oct 24;12:1389633. doi: 10.3389/fpubh.2024.1389633. eCollection 2024. Front Public Health. 2024. PMID: 39512716 Free PMC article.
Cited by
-
Hepatitis-B immune status and vaccination in Family Medicine Practice: A retrospective study.Pak J Med Sci. 2024 Jul;40(6):1163-1167. doi: 10.12669/pjms.40.6.8371. Pak J Med Sci. 2024. PMID: 38952534 Free PMC article.
-
Barriers and facilitators of integrated hepatitis B, C, and HIV screening among pregnant mothers and newborns attending maternal and newborn clinics in Koboko District, Uganda: a qualitative inquiry of providers' perspective.BMC Infect Dis. 2025 Jan 29;25(1):139. doi: 10.1186/s12879-025-10554-w. BMC Infect Dis. 2025. PMID: 39881242 Free PMC article.
-
Impact of coronavirus disease 2019 on prevention and elimination strategies for hepatitis B and hepatitis C.World J Hepatol. 2021 Jul 27;13(7):781-789. doi: 10.4254/wjh.v13.i7.781. World J Hepatol. 2021. PMID: 34367499 Free PMC article. Review.
-
Effectiveness of oral levamisole as an adjuvant to hepatitis B vaccination in healthcare workers non-responsive to previous vaccination: A randomized controlled trial.New Microbes New Infect. 2023 May 16;53:101141. doi: 10.1016/j.nmni.2023.101141. eCollection 2023 Jun. New Microbes New Infect. 2023. PMID: 37255960 Free PMC article.
-
Barriers and facilitators of integrated hepatitis B, C, and HIV screening among pregnant mothers and their newborns attending maternal and newborn clinics in Koboko District, Uganda: A qualitative inquiry of providers' perspective.Res Sq [Preprint]. 2023 Dec 18:rs.3.rs-3739602. doi: 10.21203/rs.3.rs-3739602/v1. Res Sq. 2023. Update in: BMC Infect Dis. 2025 Jan 29;25(1):139. doi: 10.1186/s12879-025-10554-w. PMID: 38196577 Free PMC article. Updated. Preprint.
References
-
- Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention (CDC) Immunization of health-care personnel: recommendations of the Advisory Committee on Immunization Practices (ACIP. MMWR Recomm Rep. 2011;60:1–45. - PubMed
-
- Azami M, Hafezi Ahmadi MR, Sayehmiri K. Hepatitis B vaccination efficacy in Iranian healthcare workers: A Meta-Analysis Study. Hepatitis Mon. 2016;17:e37781.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical